Konferenzschrift | Kongress
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783540550396
3540550399
9782287003479
2287003479
9780387550398
0387550399
- Maße
-
25 cm
- Umfang
-
XIV, 477 S.
- Sprache
-
Deutsch
- Anmerkungen
-
Ill., graph. Darst.
Literaturangaben
- Schlagwort
-
Induktionstherapie
- Ereignis
-
Veröffentlichung
- (wo)
-
Paris, Berlin, Heidelberg, New York, London, Tokyo, Hong Kong, Barcelona, Budapest
- (wer)
-
Springer
- (wann)
-
c 1991
- Beteiligte Personen und Organisationen
-
Banzet, P.
Congrès International sur la Chimiothérapie Néo-Adjuvante (3 : 1991 : Paris)
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Konferenzschrift
- Kongress
Beteiligte
- Banzet, P.
- Congrès International sur la Chimiothérapie Néo-Adjuvante (3 : 1991 : Paris)
- Springer
Entstanden
- c 1991
Ähnliche Objekte (12)
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Preoperative (neoadjuvant) chemotherapy : with 49 tables
Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy
Re-challenging taxanes in recurrent breast cancer in patients treated with (neo-)adjuvant taxane-based therapy
Pembrolizumab (NSCLC, neoadjuvant + adjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
Original article: role of adjuvant chemotherapy in a perioperative chemotherapy regimen for gastric cancer
Infectious morbidity in pediatric patients receiving neoadjuvant chemotherapy for sarcoma
Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial
Trastuzumab (Herceptin (R)): monoclonal antibody in the treatment of HER2/neu-overexpressing breast cancer in the metastatic and (neo)adjuvant situation
Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases
Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Preoperative (neoadjuvant) chemotherapy : with 49 tables
Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy
Re-challenging taxanes in recurrent breast cancer in patients treated with (neo-)adjuvant taxane-based therapy
Pembrolizumab (NSCLC, neoadjuvant + adjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
Original article: role of adjuvant chemotherapy in a perioperative chemotherapy regimen for gastric cancer
Infectious morbidity in pediatric patients receiving neoadjuvant chemotherapy for sarcoma
Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial
Trastuzumab (Herceptin (R)): monoclonal antibody in the treatment of HER2/neu-overexpressing breast cancer in the metastatic and (neo)adjuvant situation
Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases
Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Preoperative (neoadjuvant) chemotherapy : with 49 tables
Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy
Re-challenging taxanes in recurrent breast cancer in patients treated with (neo-)adjuvant taxane-based therapy
Pembrolizumab (NSCLC, neoadjuvant + adjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
Original article: role of adjuvant chemotherapy in a perioperative chemotherapy regimen for gastric cancer
Infectious morbidity in pediatric patients receiving neoadjuvant chemotherapy for sarcoma
Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial
Trastuzumab (Herceptin (R)): monoclonal antibody in the treatment of HER2/neu-overexpressing breast cancer in the metastatic and (neo)adjuvant situation
Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases